BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 83 filers reported holding BICYCLE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,433 | -28.4% | 3,705 | -9.1% | 0.04% | -27.4% |
| Q2 2023 | $103,968 | +55.4% | 4,074 | +29.5% | 0.06% | +67.6% |
| Q1 2023 | $66,894 | -48.2% | 3,145 | -27.9% | 0.04% | -44.8% |
| Q4 2022 | $129,086 | -30.6% | 4,361 | -45.5% | 0.07% | -9.5% |
| Q3 2022 | $186,000 | +39.8% | 8,009 | +0.8% | 0.07% | +51.0% |
| Q2 2022 | $133,000 | +1.5% | 7,946 | +166.0% | 0.05% | -16.9% |
| Q1 2022 | $131,000 | -32.1% | 2,987 | -5.7% | 0.06% | -19.2% |
| Q4 2021 | $193,000 | -35.0% | 3,166 | -55.6% | 0.07% | -44.3% |
| Q3 2021 | $297,000 | +30.3% | 7,130 | -5.0% | 0.13% | +39.4% |
| Q2 2021 | $228,000 | – | 7,509 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |